Citation: Dj. Evans et Dg. Evans, Helicobacter pylori CagA: Analysis of sequence diversity in relation to phosphorylation motifs and implications for the role of CagA as a virulence factor, HELICOBACT, 6(3), 2001, pp. 187-198
Citation: Dmc. Pineros et al., Helicobacter pylori in gastric cancer and peptic ulcer disease in a Colombian population. Strain heterogeneity and antibody profiles, HELICOBACT, 6(3), 2001, pp. 199-206
Citation: Js. Kim et al., Caspase-3 activity and expression of Bcl-2 family in human neutrophils by Helicobacter pylori water-soluble proteins, HELICOBACT, 6(3), 2001, pp. 207-215
Citation: K. Bodger et al., Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy, HELICOBACT, 6(3), 2001, pp. 216-224
Authors:
Annibale, B
Negrini, R
Caruana, P
Lahner, E
Grossi, C
Bordi, C
Delle Fave, G
Citation: B. Annibale et al., Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection, HELICOBACT, 6(3), 2001, pp. 225-233
Authors:
McNulty, CAM
Wilson, MP
Havinga, W
Johnston, B
O'Gara, EA
Maslin, DJ
Citation: Cam. Mcnulty et al., A pilot study to determine the effectiveness of garlic oil capsules in thetreatment of dyspeptic patients with Helicobacter pylori, HELICOBACT, 6(3), 2001, pp. 249-253
Authors:
Asaka, M
Sugiyama, T
Kato, M
Satoh, K
Kuwayama, H
Fukuda, Y
Fujioka, T
Takemoto, T
Kimura, K
Shimoyama, T
Shimizu, K
Kobayashi, S
Citation: M. Asaka et al., A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients, HELICOBACT, 6(3), 2001, pp. 254-261
Citation: Ea. Marcus et Dr. Scott, Cell lysis is responsible for the appearance of extracellular urease in Helicobacter pylori, HELICOBACT, 6(2), 2001, pp. 93-99
Authors:
Domek, MJ
Netzer, P
Prins, B
Nguyen, T
Liang, D
Wyle, FA
Warner, A
Citation: Mj. Domek et al., Helicobacter pylori induces apoptosis in human epithelial gastric cells bystress activated protein kinase pathway, HELICOBACT, 6(2), 2001, pp. 110-115
Authors:
Ohara, T
Goshi, S
Taneike, I
Tamura, Y
Zhang, HM
Yamamoto, T
Citation: T. Ohara et al., Inhibitory action of a novel proton pump inhibitor, rabeprazole, and its thioether derivative against the growth and motility of clarithromycin-resistant Helicobacter pylori, HELICOBACT, 6(2), 2001, pp. 125-129
Authors:
Paoluzi, OA
Rossi, P
Montesano, C
Bernardi, S
Carnieri, E
Marchione, OP
Nardi, F
Iacopini, F
Pica, R
Paoluzi, P
Citation: Oa. Paoluzi et al., Discrepancy between polymerase chain reaction assay and Western blot analysis in the assessment of CagA status in dyspeptic patients, HELICOBACT, 6(2), 2001, pp. 130-135
Authors:
Yamamoto, S
Kaneko, H
Konagaya, T
Mori, S
Kotera, H
Hayakawa, T
Yamaguchi, C
Uruma, M
Kusugami, K
Mitsuma, T
Citation: S. Yamamoto et al., Interactions among gastric somatostatin, interleukin-8 and mucosal inflammation in Helicobacter pylori-positive peptic ulcer patients, HELICOBACT, 6(2), 2001, pp. 136-145
Authors:
Phillips, RH
Whitehead, MW
Doig, LA
Sieniawska, CE
Delves, HT
Thompson, RPH
Powell, JJ
Citation: Rh. Phillips et al., Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?, HELICOBACT, 6(2), 2001, pp. 151-156
Authors:
Gisbert, JP
Marcos, S
Gisbert, JL
Pajares, JM
Citation: Jp. Gisbert et al., High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori eradication, HELICOBACT, 6(2), 2001, pp. 157-162
Authors:
Demirturk, L
Ozel, AM
Yazgan, Y
Solmazgul, E
Yildirim, S
Gultepe, M
Gurbuz, AK
Citation: L. Demirturk et al., CagA status in dyspeptic patients with and without peptic ulcer disease inTurkey: Association with histopathologic findings, HELICOBACT, 6(2), 2001, pp. 163-168